<?xml version="1.0" encoding="UTF-8"?>
<results title="migration">
 <result pre="Heat shock protein 90 inhibitor AUY922 attenuates platelet-derived growth factor-BB-induced" exact="migration" post="and proliferation of vascular smooth muscle cells KimJisu1#LeeKang Pa2#KimBom"/>
 <result pre="of AUY922 on the platelet-derived growth factor (PDGF)-BB-stimulated proliferation and" exact="migration" post="of vascular smooth muscle cells (VSMC). VSMC viability was"/>
 <result pre="To detect the attenuating effects of AUY922 on PDGF-BB-induced VSMCs" exact="migration" post="in vitro, we performed the Boyden chamber and scratch"/>
 <result pre="was analyzed by immunoblotting. The inhibitory effects of AUY922 on" exact="migration" post="and proliferation ex vivo were tested using an aortic"/>
 <result pre="ERK1/2 inhibitor) and LY294002 (a selective Akt inhibitor) decreased VSMC" exact="migration" post="and proliferation by inhibiting phosphorylation of Akt and ERK1/2."/>
 <result pre="Akt and ERK1/2. Greater attenuation of PDGF-BB-induced cell viability and" exact="migration" post="was observed upon treatment with PD98059 or LY294002 in"/>
 <result pre="[3]. Diverse non-clinical trials have reported that controlling abnormal VSMC" exact="migration" post="and hyper-proliferation, which narrows the vascular wall, is a"/>
 <result pre="inhibition can improve vascular disease via the suppression of VSMC" exact="migration" post="and proliferation [11]. AUY922, also known as luminespib, is"/>
 <result pre="responses of PDGF-BB-stimulated VSMCs. We found that AUY922 attenuates PDGF-BB-induced" exact="migration" post="and proliferation in VSMCs. METHODS Materials AUY922 was purchased"/>
 <result pre="and evaluated under a microscope (IX71; Olympus, Tokyo, Japan). The" exact="migration" post="area was analyzed using ImageJ (NIH, Bethesda, MD, USA)."/>
 <result pre="using ImageJ (NIH, Bethesda, MD, USA). Boyden chamber assay VSMCs" exact="migration" post="was measured using the Boyden chamber assay, as previously"/>
 <result pre="of PDGF-BB, significantly reduced PDGF-BB-induced VSMC growth. AUY922 attenuates the" exact="migration" post="of PDGF-BB-induced VSMCs We investigated whether AUY922 can regulate"/>
 <result pre="To determine the inhibitory effect of AUY922 against PDGF-BB-induced VSMCs" exact="migration" post="in the short-term, we performed a Boyden chamber assay."/>
 <result pre="Next, we confirmed the inhibitory effect of AUY922 on the" exact="migration" post="of PDGF-BB-induced VSMCs after 24 h using a scratch"/>
 <result pre="wound healing assay. As shown in Fig. 2B, PDGF-BB-induced VSMC" exact="migration" post="was significantly reduced by AUY922 in a dose-dependent manner."/>
 <result pre="manner. To confirm the inhibitory effect of AUY922 on VSMC" exact="migration" post="by PDGF-BB, we performed an aortic sprout outgrowth assay."/>
 <result pre="of Akt and ERK1/2 phosphorylation is related to the abnormal" exact="migration" post="and proliferation of VSMCs [11]. Accordingly, we analyzed the"/>
 <result pre="the Boyden chamber assay (Fig. 4B), the PDGF-BB-induced increase in" exact="migration" post="was significantly reduced by PD98059 or LY294002 and AUY922"/>
 <result pre="combined treatment with PD98059 or LY294002 and AUY922 increased PDGF-induced" exact="migration" post="to 122.6 ± 10.0% and 110.0 ± 10.3%, respectively."/>
 <result pre="that AUY922, an HSP90 inhibitor, inhibits PDGF-BB-induced increases in VSMC" exact="migration" post="and proliferation. Moreover, AUY922 significantly reduced ERK1/2 and Akt"/>
 <result pre="signaling cascades, including MAPK and Akt, to regulate PDGF-BB-induced VSMC" exact="migration" post="and proliferation. Excessive migration and proliferation of VSMCs by"/>
 <result pre="and Akt, to regulate PDGF-BB-induced VSMC migration and proliferation. Excessive" exact="migration" post="and proliferation of VSMCs by PDGF-BB have been implicated"/>
 <result pre="development [16]. PDGF-BB induces the phosphorylation of PDGFR and abnormal" exact="migration" post="and proliferation of VSMCs [17,18]. Thus, controlling PDGFR phosphorylation"/>
 <result pre="[22]. In our study, AUY922 significantly reduced the proliferation and" exact="migration" post="of PDGF-BB-induced VSMCs in vitro and ex vivo. Therefore,"/>
 <result pre="that PDGF-BB is closely related to the excessive proliferation and" exact="migration" post="of VSMCs via Akt and ERK1/2 phosphorylation. LY294002 (a"/>
 <result pre="that AUY922 greater than PD98059 or LY294002 in the PDGF-BB-induced" exact="migration" post="and proliferation (Fig. 4). Therefore, we suggest that HSP90"/>
 <result pre="underlying HSP90 [25]. PDGF-BB-induced ROS can induce the abnormal VSMC" exact="migration" post="and proliferation through regulating the phosphorylation of ERK1/2 and"/>
 <result pre="factorsProg Growth Factor Res317720610.1016/0955-2235(91)90006-P1811790 6JawienABowen-PopeDFLindnerVSchwartzSMClowesAW1992Platelet-derived growth factor promotes smooth muscle" exact="migration" post="and intimal thickening in a rat model of balloon"/>
 <result pre="Transl Res1150951830788006 11KimJJangSWParkEOhMParkSKoJ2014The role of heat shock protein 90 in" exact="migration" post="and proliferation of vascular smooth muscle cells in the"/>
 <result pre="in triple-negative breast cancer cellsOncotarget810419310420510.18632/oncotarget.2211929262632 14BaekSLeeKPCuiLRyuYHongJMKimJJungSHBaeYMWonKJKimB2017Low-power laser irradiation inhibits PDGF-BB-induced" exact="migration" post="and proliferation via apoptotic cell death in vascular smooth"/>
 <result pre="perspectives and therapeutic strategiesNat Med81249125610.1038/nm1102-124912411952 17KangHAhnDHPakJHSeoKHBaekNIJangSW2016Magnobovatol inhibits smooth muscle cell" exact="migration" post="by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expressionInt"/>
</results>
